Angiotensinogen Gene Missense Polymorphisms (rs699 and rs4762): The Association of End-Stage Renal Failure Risk with Type 2 Diabetes and Hypertension in Egyptians

• Published in: Genes Vol. 12; no. 3; p. 339
• Main Authors: El-Garawani, Islam M, Shaheen, Eman M, El-Seedi, Hesham R, Khalifa, Shaden M A, Mersal, Gaber A M, Emara, Mahmoud M, Kasemy, Zeinab A
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 25.02.2021
• Subjects: angiotensinogen polymorphism; diabetic nephropathy; end-stage renal failure; hypertension; rs4762; rs699; angiotensinogen polymorphism; end-stage renal failure; rs4762; hypertension; diabetic nephropathy; rs699
• ISSN: 2073-4425; 2073-4425
• DOI: 10.3390/genes12030339

Type 2 diabetes mellitus (T2DM) and hypertension are common chronic diseases mainly associated with the development and progression of end-stage renal disease (ESRD) leading to morbidity and mortality. Gene polymorphisms linked to the renin-angiotensin ( )-aldosterone system (RAAS) were broadly inspected in patients with diabetic nephropathy (DN) and hypertension. This study aimed to investigate the association of gene polymorphisms (rs699 and rs4762) with ESRD in T2DM hypertensive Egyptian patients. Genotyping of rs699 and rs4762 was conducted using the tetra-primers amplification refractory mutation system (ARMS-PCR). The allelic distribution analysis was performed on 103 healthy control subjects, 97 non-ESRD patients, and 104 patients with ESRD. The allelic frequencies of gene polymorphisms (rs4762 and rs699) in all study participants were assessed. For the non-ESRD group, the frequencies of the alleles of -rs4762 ( = 31.88, < 0.001, OR = 5.17, CI 95%: 2.81-9.51) and -rs699 ( = 4.85, = 0.027, OR = 1.56, CI 95%: 1.05-2.33) were significantly associated with the non-ESRD group. However, for the ESRD group, the T allele was significantly higher than that in the controls ( = 24.97, < 0.001, odds ratio (OR) = 4.35, CI 95%: 2.36-8.02). Moreover, (rs699) genotypes showed no significant difference between the ESRD group and controls. In conclusion, gene polymorphisms rs699 and rs4762 were associated with non-ESRD versus controls, without any significant risk observed in all patient groups. However, the (rs4762) variant showed a significant risk in the ESRD group in comparison to controls in Egyptians.